Skip to main content
SpringerLink
Log in
Book cover

Nisoldipine 1987 pp 307–314Cite as

Hemodynamic Effects of Nisoldipine in Patients with Severe Heart Failure

  • Conference paper

Summary

To determine the effects of nisoldipine in patients with severe left ventricular dysfunction, we studied hemodynamic changes after oral nisoldipine in 14 patients with severe chronic congestive heart failure . They included 9 males and 5 females, with a mean age of 72 years. Three patients were classified as NYHA Class III and 11 patients, as Class IV . Baseline hemodynamics included a mean left ventricular ejection fraction of 26% ± 14% and a mean cardiac index of 1.98 ± 0.34 liter min−1m−2. Beta blockers, vasodilators or inotropic drugs were discontinued. Heart rate, blood pressure, pulmonary artery wedge pressure, and cardiac output were stable for at least 1 h prior to the study. Baseline hemodynamic measurements and radionuclide angiocardiography were then obtained. An oral dose of nisoldipine (5, 10, or 20 mg) in a double-blind fashion was administered according to random assignment. Measurements of hemodynamics were obtained at 30 min, 1,2,3,4, 5, 6, 7, and 8 h thereafter. Repeat radionuclide imaging was performed 2 and 3 h following nisoldipine administration. Hemodynamic measurements included: heart rate (HR, bpm), arterial pressure (AP, mmHg), right atrial pressure (RAP, mmHg), pulmonary arterial pressure (PAP, mmHg), pulmonary capillary wedge pressure (PCW, mmHg), systemic vascular resistance (SVR, dyn s−1 cm−5), left ventricular ejection fraction (LVEF%), cardiac index (CI, liter min−1 m−2) and stroke volume index (SVI, cc b−1 m−2).

Peak systemic hemodynamic effect or maximal fall in systemic vascular resistance was variable in time of onset for individuals. The maximal fall in systemic vascular resistance was obtained an average of 2.8 ± 1.6 h after the oral dose of nisoldipine. Since there were wide variations among individuals with regard to the time of peak systemic hemodynamic effect , we analyzed individual hemodynamic changes at peak effect of nisoldipine.

We conclude from this study that acute administration of oral nisoldipine may be efficacious in certain patients with chronic congestive heart failure. Improved left ventricular function with nisoldipine may be associated with reduction in mean PCW and determinants of afterload, i.e. AP and SVR.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Low RI, Takeda P, Mason DT, DeMaria AN (1982) The effects of calcium channel blocking agents on cardiovascular function. Am J Cardiol 49: 547–553

    Article  PubMed  CAS  Google Scholar 

  2. Ellrodt AG, Singh BN (1983) Clinical applications of slow channel blocking compounds. Pharmacal Ther 23: 1–43

    Article  CAS  Google Scholar 

  3. Schwartz A, Matlib MA, Balwierczak J, Lathrop DA (1985) Pharmacology of calcium antagonists. Am J Cardiol 55: 3C–7C

    Article  PubMed  CAS  Google Scholar 

  4. Josephson MA, Singh BN (1985) Use of calcium antagonists in ventricular dysfunction. Am J Cardiol 55: 81B–88B

    Article  PubMed  CAS  Google Scholar 

  5. Baughman K (1986) Calcium channel blocking agents in congestive heart failure. Am J Med 80 [suppl 213]: 46–50

    Article  PubMed  CAS  Google Scholar 

  6. Colucci WS (1987) Usefulness of calcium antagonists for congestive heart failure. Am J Cardiol 59: 52B–58B

    Article  PubMed  CAS  Google Scholar 

  7. O’Rourke RA, Walsh RA (1982) Experience with calcium antagonist drugs in congestive heart failure. Am J Cardiol 59: 64B–69B

    Article  Google Scholar 

  8. Kazda S, Garthoff B, Meyer H, Schlossmann K, Stoepel K, Towart R, Vater W, Wehinger E (1980) Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1, 4-dihydro-2, 6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate (nisoldipine, Bay k 5552). Arzneimittelforsch Drug Res 30 (II): 2144–2162

    CAS  Google Scholar 

  9. Vogt A, Neuhaus KL, Kreuzer H (1980) Hemodynamic effects of the new vasodilator drug Bay k 5552 in man. Arzneimittelforsch Drug Res 32 (II): 2162–2164

    Google Scholar 

  10. Warltier DC, Meils CM, Gross GJ, Brooks HL (1981) Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist. J Pharmacol and Exp Therap 218: 296–302

    CAS  Google Scholar 

  11. Maxwell GM, Crompton S, Rencis V (1982) Effect of nisoldipine upon the general and coronary hemodynamics of the anesthetized dog. J Cardiovasc Pharmacol 4: 393–397

    Article  PubMed  CAS  Google Scholar 

  12. Serruys PW, Suryapranata H, Planellas J, Wijns W, Vanhaleweyk GLJ, Soward A, Jaski BE, Hugenholtz PG (1985) Acute effects of intravenous Nisoldipine on left ventricular function and coronary hemodynamics. Am J Cardiol 56: 140–146

    Article  PubMed  CAS  Google Scholar 

  13. Soward AL, DeFeyter PJ, Hugenholtz PG, Serruys PW (1986) Coronary and systemic hemodynamic effects of intravenous nisoldipine. Am J Cardiol 58: 1199–1203

    Article  PubMed  CAS  Google Scholar 

  14. Soward AL, DeFeyter PJ, Hugenholtz PG, Serruys PW (1986) Maintenance of increased or blood flow in excess of demand by nisoldipine administered as an intravenous infusion. Am J Cardiol 58: 1204–1208

    Article  PubMed  CAS  Google Scholar 

  15. Kimchi A, Ellrodt AG, Shah PK, Riedinger MS, Berman DS, Swan HJC, Murata GH (1985) Salutary hemodynamic effects of nisoldipine (Bay k 5552), a new calcium channel blocker, in patients with severe chronic congestive heart failure. JACC 5: 420

    Google Scholar 

  16. Kimchi A, Ellrodt AG, Charuzi Y, Shell W, Murata GM (1985) Salutary hemodynamic and sustained clinical beneficial effects of nisoldipine, a new calcium channel blocker, in patients with recurrent ischemia and severe heart failure. Am Heart J 110: 496–498

    Article  PubMed  CAS  Google Scholar 

  17. Kimchi A, Rozanski A, Fletcher C, Maddahi J, Swan HJC, Berman D (1985) Reversal of rest myocardial asynergy during exercise: a radionuclide scintigraphic study. JACC 6: 1004–1010

    PubMed  CAS  Google Scholar 

  18. Kimchi A, Ellrodt G, Berman D, Riedinger M, Swan HJC, Murata G (1984) Right ventricular performance in septic shock: A combined radionuclide and hemodynamic study. JACC 4: 945–951

    PubMed  CAS  Google Scholar 

  19. Vogt A, Kreuzer H (1983) Hemodynamic effects of Nisoldipine in chronic congestive heart failure. Arzneimittelforsch Drug Res 33 (I): 877–879

    CAS  Google Scholar 

  20. Klepzig M, Straver BB (1985) Nisoldipine for treatment of heart failure? Eur J Clin Invest 15: A11

    Google Scholar 

  21. Kiowski W, Erne P, Pfisterer M, Muller J, Burkart F (1985) Hemodynamic effects of nisoldipine in patients with severe left ventricular failure. Circulation 72: III-407

    Google Scholar 

  22. Nienaber CA, Spielmann RP, Clausen A (1985) Acute hemodynamic response to intravenous nisoldipine in ischemic cardiomyopathy- comparison with nifedipine. Circulation 92: III-407

    Google Scholar 

  23. Schmidt WG, Essen RV, Flachskampf FA, Schmitz E (1986) Hemodynamic effects of Nisoldipine in acute cardiac failure after myocardial infarction. JACC 72: 180A

    Google Scholar 

  24. Chew YC, Hecht HS, Colleit JT, McAllister RG, Singe BN (1981) Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil ischemic heart disease. Am J Cardiol 47: 917–922

    Article  PubMed  CAS  Google Scholar 

  25. Ferlinz J, Citron PD (1983) Hemodynamic and myocardial performance characteristics after Verapamil use in congestive heart failure. Am J Cardiol 51: 1339–1345

    Article  PubMed  CAS  Google Scholar 

  26. Guazzi MD, Cipolla C, Bella PD, Fabbiocchi F, Montorsi P, Sganzerla P (1984) Disparate unloading efficacy of the calcium channel blockers, verapamil and nifedipine, on the failing hypertensive left ventricle. Am Heart J 108: 116–123

    Article  PubMed  CAS  Google Scholar 

  27. Kopman EA (1985) Intravenous verapamil to relieve pulmonary congestion in patients with mitral valve disease. Anesthesiology 56: 374–376

    Google Scholar 

  28. Epstein ML, Kiel EA, Victorica BE (1985) Cardiac decompensation following Verapamil therapy in infants with supraventricular tachycardia. Pediatrics 75: 737–740

    PubMed  CAS  Google Scholar 

  29. Bjornstad PO, Storstein L, Semb BKH (1986) Verapamil effects on left ventricular performance in patients with congestive heart failure studied with echocardiography before and after cardiac surgery. Scan J Thor Cardiovasc Surg 20: 61–66

    Article  CAS  Google Scholar 

  30. Materne P, Legrand V, Vandormael M, Collignon P, Kulbertus HE (1984) Hemodynamic effects of intravenous Diltiazem with impaired left ventricular function. Am J Cardiol 54: 733–737

    Article  PubMed  CAS  Google Scholar 

  31. Walsh RW, Porter CB, Starling MR, O’Rourke RA (1984) Beneficial hemodynamic effects of intravenous and oral Diltiazem in severe congestive heart failure. JACC Vol. 3, No. 4: 1044–1050

    PubMed  CAS  Google Scholar 

  32. Strauss WE, Egan T, Mcintyre KM, Parisi AF (1985) Combination therapy with diltiazem and propranolol Precipitation of congestive heart failure. Clin Cardiol 8: 363–366

    Article  PubMed  CAS  Google Scholar 

  33. Polese A, Fiorentini C, Olivari MT, Guazzi MD (1979) Clinical use of a calcium antagonist agent (nifedipine) in acute pulmonary edema. Am J Med 66: 825–830

    Article  PubMed  CAS  Google Scholar 

  34. Gillmer DJ, Kark P (1980) Pulmonary oedema precipitated by nifedipine. Br Med J 280: 1420–1421

    Article  PubMed  CAS  Google Scholar 

  35. Matsumoto S, Ito T, Sada T, Takahashi M, Su KM, Ueda A, Okabe F, Cato M, Sekine I, Ito Y (1980) Hemodynamic effects of nifedipine in congestive heart failure. Am J Cardiol 46: 476–480

    Article  PubMed  CAS  Google Scholar 

  36. Brooks N, Cattell M, Pidgeon J, Balcon R (1980) Unpredictable response to nifedipine in severe cardiac failure. Br Med J 281: 1324

    Article  PubMed  CAS  Google Scholar 

  37. Cantelli I, Pavesi PC, Naccarella F, Bracchetti D (1981) Comparison of acute hemodynamic effects of nifedipine and isosorbide dinitrate in patients with heart failure following acute myocardial infarction. Int J Cardiol 1: 151–163

    Article  PubMed  CAS  Google Scholar 

  38. Ludbrook PA, Tiefenbrunn AJ, Sobel BE, Reed FR (1981) Influence of nifedipine on left ventricular systolic and diastolic function. Relationships to manifestations of ischemia and congestive failure. Am J Med 71: 683–692

    Article  PubMed  CAS  Google Scholar 

  39. Robson RH, Vishwanath MC (1982) Nifedipine and beta-blockade as a cause of cardiac failure. Br Med J 284: 104

    Article  CAS  Google Scholar 

  40. Ludbrook PA, Tiefenbrunn AJ, Reed FR, Sobel BE (1982) Acute hemodynamic responses to sublingual nifedipine: Dependence on left ventricular function. Circulation 65: 489–498

    Article  PubMed  CAS  Google Scholar 

  41. Cantelli I, Pavesi PC, Parchi C, Naccarella F, Bracchetti D (1983) Acute hemodynamic effects of combined therapy with digoxin and nifedipine in patients with chronic heart failure. Am Heart J 106: 308–315

    Article  PubMed  CAS  Google Scholar 

  42. Elkayam U, Weber L, Torkan B, Berman D Rahimtoola SH (1983) Acute hemodynamic effect of oral nifedipine in severe chronic congestive heart failure. Am J Cardiol 52: 1041–1045

    Article  PubMed  CAS  Google Scholar 

  43. Leier CV, Patrick TJ, Hermiller J, Pacht KD, Huss P, Magorien RD, Unverferth DV (1984) Nifedipine in congestive heart failure: Effects on resting and exercise hemodynamics and regional blood flow. Am Heart J 108: 1461–1468

    Article  PubMed  CAS  Google Scholar 

  44. Elkayam U, Weber L, Torkan B, McKay CR, Rahimtoola SH (1984) Comparison of hemodynamic responses to nifedipine and nitroprusside in severe chronic congestive heart failure. Am J Cardiol 53: 1321–1325

    Article  PubMed  CAS  Google Scholar 

  45. Elkayam U, Weber R, McKay CR, Rahimtoola SH (1984) Differences in hemodynamic response to vasodilation due to calcium channel antagonism with nifedipine and direct -acting agonism with hydralazine in chronic refractory congestive heart failure. Am J Cardiol 54: 126–131

    Article  PubMed  CAS  Google Scholar 

  46. Magorien RD, Leier CV, Kolibash AJ, Bar bush TJ, Unverferth DV (1984) Beneficial effects of nifedipine on rest and exercise myocardial energetics in patients with congestive heart failure. Circulation 70: 884–890

    Article  PubMed  CAS  Google Scholar 

  47. Elkayam U, Weber L, Campese VM, Massry SG, Rahimtoola SH (1984) Renal hemodynamic effects of vasodilation with nifedipine and hydralazine in patients with heart failure. JACC 4: 1261–1267

    PubMed  CAS  Google Scholar 

  48. Fifer MA, Colucci WS, Lorell BH, Jaski BE, Barry WH (1985) Inotropic, vascular and neurodocrine effects of nifedipine in heart failure: Comparison with nitroprusside. J Am Coli Cardiol 5: 731–737

    Article  CAS  Google Scholar 

  49. Miller AB, Conetta DA, Bass TA (1985) Sublingual nifedipine: Acute effects in severe chronic congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol 55: 1359–1362

    Article  PubMed  CAS  Google Scholar 

  50. Gertz MA, Falk RH, Skinner M, Cohen AS, Kyle RA (1985) Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents. Am J Cardiol 55: 1645

    Article  PubMed  CAS  Google Scholar 

  51. Elkayam U, Weber L, McKay C, Rahimtoola S (1985) Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure. Am J Cardiol 56: 560–566

    Article  PubMed  CAS  Google Scholar 

  52. Kubo SH, Fox SC, Prida XE, Cody RJ (1985) Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure. Am Heart J 110: 1032–1034

    Article  PubMed  CAS  Google Scholar 

  53. Agostoni PG, DeCesare N, Doria E, Palese A, Tamborini G, Guazzi MD (1986) Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy. Br Heart J 55: 391–399

    Article  PubMed  CAS  Google Scholar 

  54. Elkayam U, Roth A, Hsueh W, Weber L, Freidenberger L, Rahimtoola SH (1986) Neurohumoral consequences of vasodilator therapy with hydralazine and nifedipine in severe congestive heart failure. Am Heart J 111: 1130–1138

    Article  PubMed  CAS  Google Scholar 

  55. Lefkowitz CA, Moe GW, Armstrong PW (1987) A comparative evaluation of hemodynamic and neurohumoral effects of nitroglycerin and nifedipine in congestive heart failure. Am J Cardiol 59: 59B–63B

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. Kimchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. G. Ellrodt
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. K. Shah
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. S. Riedinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Charuzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. S. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H. J. C. Swan
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Medical Faculty, Thoraxcenter, Erasmus University Rotterdam, Postbus 1738, NL-3002 DR, Rotterdam, The Netherlands

    P. G. Hugenholtz

  2. II. Med. Klinik und Poliklinik, Klinikum der Universität Mainz, Postfach 3960, D-6500, Mainz, Germany

    J. Meyer

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Kimchi, A. et al. (1987). Hemodynamic Effects of Nisoldipine in Patients with Severe Heart Failure. In: Hugenholtz, P.G., Meyer, J. (eds) Nisoldipine 1987. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73010-8_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73010-8_48

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18394-5

  • Online ISBN: 978-3-642-73010-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation